Clinical experience with a new coronary-active substance (BAY 1 1040).
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D003998:Dicarboxylic Acids / Q000009:adverse effects / Q000627:therapeutic use; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009578:Nitrobenzenes / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents